Details

---

Manufacturer
NOVUGEN ONCOLOGY SDN. BHD.(MALAYSIA)
Registraction Number
MAL24116025AZ

Here’s a detailed overview of Pazorene 400mg Film Coated Tablets:

Content

Active Ingredient: Pazopanib hydrochloride (433.4 mg), equivalent to 400 mg of Pazopanib.
Excipients: Includes lactose monohydrate, microcrystalline cellulose, and other inactive ingredients.

Indications

Renal Cell Carcinoma (RCC): Used for the treatment of advanced and/or metastatic RCC.
Soft Tissue Sarcoma (STS): Prescribed for advanced STS in patients who have received prior chemotherapy. Note: It excludes gastrointestinal stromal tumors (GIST) or adipocytic STS.

Instructions

Dosage:
The recommended dose is 800 mg orally once daily. For patients with moderate hepatic impairment, the dose may be reduced to 200 mg daily.
Administration:
Take the tablet on an empty stomach, either at least one hour before or two hours after food.
Swallow the tablet whole with water; do not crush or break it.